| http://www.w3.org/ns/prov#value | - Such potential risks and uncertainties include, without limitation, the ability for the Company to derive business partnerships or future revenue streams using the Aethlon ADAPT??? system including the ability to introduce a targeted breast cancer therapy known as HER2osome???, there is no assurance that FDA will approve the initiation of the company???s clinical programs or provide market clearan
|
